Overview
Feebris is an innovative healthcare technology company that leverages AI-powered mobile platforms to improve diagnosis and monitoring in community-based healthcare. Founded by Elina Naydenova, the company's mission is to transform healthcare delivery by enabling both non-clinical and clinical users to collect, interpret, and share precise health measurements, thereby facilitating early disease detection and ongoing monitoring—particularly in underserved areas.
Leadership Team
- Elina Naydenova: CEO and Co-Founder
- Background: Biomedical & AI Engineer with a Ph.D. in Machine Learning for Healthcare Innovation from Oxford University.
- Awards: Recognized as the 'Female Entrepreneur of the Year' at the 2020 GIANT Health Event Awards.
- Impact: Known for digital healthcare contributions, particularly through Feebris’s platform, which helps health workers provide more personalized and effective care.
- Adam Bacon: Co-Founder & COO
- Sebastian Durandeu: Head of Software Engineering
- Eduardo Gallego: Head Commercial UK
- Seema Odedra: Senior Account Executive
- Role: Focused on enhancing resident safety and carer efficiency through technological advancements, notably at industry events.
- Emily Pride: Senior Clinical Operations Specialist
- Credentials: NMC Registered Nurse Associate
- Focus: Utilizes clinical expertise to improve patient care within digital health frameworks.
Recent Developments and Technological Innovations
Feebris has been highlighted in studies demonstrating the pivotal role of AI-guided virtual care, underscoring the platform's ability to provide critical data for informed clinical decisions, reduce unnecessary hospital admissions, and enable real-time remote patient audits. The cloud-based, device-agnostic platform supports remote monitoring via wireless connectivity and AI enhancement, enabling integration with various medical devices to capture patient data seamlessly.
Market and Partnerships
Feebris has established partnerships with key organizations, including the NHS Innovation Accelerator, showcasing its capacity to lead innovation in healthcare delivery. The platform offers targeted solutions tailored to the regulatory and healthcare needs of UK and US providers, along with comprehensive user training to maximize platform use and enhance care delivery.
Strategic Insights
Feebris aims to empower community and primary care workforces through AI-powered tools that improve data capture accuracy and healthcare delivery efficiency. The technology aids in triage and prioritization, ensuring timely treatment pathways and optimizing healthcare resources. This strategic vision and capability position Feebris as a central player in digital healthcare transformation, especially in community-based settings.
Financial & Employee Overview
- Estimated Annual Revenue: $7.8 million
- Number of Employees: 31
- Revenue Per Employee: $251,000
- Employee Growth Rate: 11% over the past year
Competitors
Feebris operates in a competitive healthcare landscape with notable comparisons being:
1. Vision RT: Revenue - $86.6 million, Employees - 345; Specializes in enhancing radiotherapy treatments via Surface Guided Radiation Therapy (SGRT).
2. CMR Surgical: Revenue - $369.5 million, Employees - 920; Develops robotic systems for minimal access surgery.
3. NRS Healthcare: Revenue - $136 million, Employees - 542; Provides products/services for independent living, working notably with the NHS.
4. Corin Group: Revenue - $258.8 million, Employees - 1,031; Focuses on orthopaedic technologies with AI-enhanced implants.
5. Sharp Life Sciences (EU) Limited: Revenue - $1 million, Employees - 4; Provides aQdrop technology for fluid control in labs.
Market Positioning and Unique Value
Feebris stands out in the AI healthcare domain by offering a sophisticated diagnostic platform that lowers traditional barriers to detecting respiratory diseases. Their solution is designed to expand beyond hospital environments, promoting democratized access to crucial diagnostic tools. This position allows Feebris to extend its client base across diverse healthcare markets, especially for conditions that often require specialized consultation.
